Stocksigma LogoStocksigma Logo

Sai Life Sciences Reports Q2 Results, Key Leadership Appointments, and Equity Allotment

For Q2 ended 30th Sep'26, Sai Life Sciences posted consolidated revenue from operations of ₹6,585.85 mn, up 22.5% YoY, and profit after tax of ₹983.17 mn

Sai Life Sciences Reports Q2 Results, Key Leadership Appointments, and Equity Allotment

Sai Life Sciences Ltd · Others (Uncategorized) · 06 Nov 2026, 4:39 am

Sai Life Sciences Reports Q2 Results, Key Leadership Appointments, and Equity Allotment For Q2 ended 30th Sep'26, Sai Life Sciences posted consolidated revenue from operations of ₹6,585.85 mn, up 22.5% YoY, and profit after tax of ₹983.17 mn versus ₹838.44 mn in Q2'25. Basic EPS stood at ₹4.63. The Board approved the appointments of Sidhartha Das as SVP & Head HR, Vijay Kumar Suthari as VP Head Quality & Regulatory Affairs, and Sriram Gopalakrishnan as SVP Corporate Communications. Additionally, the company allotted 1,08,005 equity shares under its ESOP and MESOP schemes, expanding paid-up capital to ₹21,25,80,721.

Original exchange filing (PDF)

More announcements from Sai Life Sciences Ltd

All Sai Life Sciences Ltd announcements